Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

被引：0
|
作者：
Makoto Natsume
Takaya Shimura
Hiroyasu Iwasaki
Yusuke Okuda
Mika Kitagawa
Yasuyuki Okamoto
Kazuki Hayashi
Hiromi Kataoka
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and Metabolism
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Angiogenesis; Biomarker; Gastric cancer; PlGF; Ramucirumab; VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1037 / 1046
页数：9
相关论文
共 50 条
  • [1] Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
    Natsume, Makoto
    Shimura, Takaya
    Iwasaki, Hiroyasu
    Okuda, Yusuke
    Kitagawa, Mika
    Okamoto, Yasuyuki
    Hayashi, Kazuki
    Kataoka, Hiromi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (06) : 1037 - 1046
  • [2] Ramucirumab: targeting angiogenesis in the treatment of gastric cancer
    Smyth, Elizabeth C.
    Tarazona, Noelia
    Chau, Ian
    IMMUNOTHERAPY, 2014, 6 (11) : 1177 - 1186
  • [3] Clinical utility of ramucirumab in advanced gastric cancer
    Chan, Matthew M. K.
    Sjoquist, Katrin M.
    Zalcberg, John R.
    BIOLOGICS-TARGETS & THERAPY, 2015, 9 : 93 - 105
  • [4] Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma
    Young, Kate
    Smyth, Elizabeth
    Chau, Ian
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (06) : 373 - 383
  • [5] RAMUCIRUMAB AND ITS USE IN GASTRIC CANCER TREATMENT
    Bronte, G.
    Galvano, A.
    Cicero, G.
    Passiglia, F.
    Rolfo, C.
    Bazan, V.
    Russo, A.
    DRUGS OF TODAY, 2014, 50 (09) : 613 - 621
  • [6] Ramucirumab: A Review in Advanced Gastric Cancer
    Greig, Sarah L.
    Keating, Gillian M.
    BIODRUGS, 2015, 29 (05) : 341 - 351
  • [7] Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers
    ElHalawani, Hesham
    Abdel-Rahman, Omar
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1123 - 1132
  • [8] Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer
    Izawa, Naoki
    Sunakawa, Yu
    Doi, Ayako
    Arai, Hiroyuki
    Horie, Yoshiki
    Hirakawa, Mami
    Mizukami, Takuro
    Ogura, Takashi
    Tsuda, Takashi
    Nakajima, Takako Eguchi
    ONCOLOGY, 2019, 97 (02) : 94 - 101
  • [9] BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer
    Tomohiro Kubo
    Yutaka Kawano
    Nobuaki Himuro
    Shintaro Sugita
    Yasushi Sato
    Kazuma Ishikawa
    Kohichi Takada
    Kazuyuki Murase
    Koji Miyanishi
    Tsutomu Sato
    Rishu Takimoto
    Masayoshi Kobune
    Takayuki Nobuoka
    Koichi Hirata
    Tetsuji Takayama
    Mitsuru Mori
    Tadashi Hasegawa
    Junji Kato
    Gastric Cancer, 2016, 19 : 827 - 838
  • [10] BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer
    Kubo, Tomohiro
    Kawano, Yutaka
    Himuro, Nobuaki
    Sugita, Shintaro
    Sato, Yasushi
    Ishikawa, Kazuma
    Takada, Kohichi
    Murase, Kazuyuki
    Miyanishi, Koji
    Sato, Tsutomu
    Takimoto, Rishu
    Kobune, Masayoshi
    Nobuoka, Takayuki
    Hirata, Koichi
    Takayama, Tetsuji
    Mori, Mitsuru
    Hasegawa, Tadashi
    Kato, Junji
    GASTRIC CANCER, 2016, 19 (03) : 827 - 838
12345